Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic - A case report

被引:14
|
作者
Muller, Elisabeth [1 ]
Hillemacher, Thomas [1 ]
Muller, P. Christian [2 ]
机构
[1] Paracelsus Med Univ, Dept Psychiat & Psychotherapy, Nurnberg, Germany
[2] Friedrich Alexander Univ Erlangen Nurnberg, Univ Clin, Dept Psychiat & Psychotherapy, Schwabachanlage 6, D-91054 Erlangen, Germany
关键词
Kratom; Stress; Depression management; Drug instrumentalization; Tinnitus; Sudden hearing loss; MITRAGYNA-SPECIOSA USERS; STRESS; HEALTH; ABUSE;
D O I
10.1016/j.heliyon.2021.e07039
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Kratom is a psychoactive plant preparation originating from Southeast Asia. It has been used as a recreational and performance drug in Southeast Asia, and is now increasingly used in Europe and the U.S. Case report: We describe the case of a 63-year-old man who presented for treatment after his long-term Kratom use failed as a self-management for persistent major depression (ICD 10: F33.2) and a generalized anxiety disorder (ICD-10: F41.1). The failure coincided with emerging stress at the beginning of the COVID-19 pandemic. The patient suffered from childhood on from ruminative thinking and depressive mood, which was treated in several settings during his life. He started to use alcohol to control his depression, but developed an alcohol addiction. This was successfully treated and the patient remained abstinent for more than 25 years afterwards. About 7 years ago, he started to use Kratom 3-4 times daily on a regular, but constant rate. Kratom use worked efficiently as a self-management of his depression with no escalation of dosing. It was also very effective in reducing Morbus Meniere symptoms of tinnitus and sudden hearing loss, which eventually allowed regular performance as a caregiver in a demanding job on shift-work. During recently increased stress load in the work environment and the COVID-19 pandemic, the established Kratom doses failed to control hyperarousal and mental nervousness.The patient was treatment seeking and subsequently detoxified from Kratom. Anxiety- and depression management was shifted to treatment attempts with Lorazepam, Venlafaxine, Opipramol, Mirtazapine and psychotherapy. Conclusion: Kratom instrumentalization for self-management of depression and anxiety may effectively work without causing escalation of drug use and addiction, but may be limited by a temporary increase in psychological stress load and a relapse into major depression and generalized anxiety disorder.
引用
下载
收藏
页数:4
相关论文
共 50 条
  • [1] Diabetes self-management during the covid-19 pandemic and its associations with covid-19 anxiety syndrome, depression, and health anxiety
    Semere, S.
    Malik, M. M. A. H.
    Distaso, W.
    Al Hakami, A.
    Alexander, E.
    McKechnie, V.
    Semere, S.
    Suba, K.
    Nikcevic, A.
    Oliver, N.
    Spada, M.
    Salem, V.
    DIABETIC MEDICINE, 2022, 39
  • [2] Diabetes self-management during the COVID-19 pandemic and its associations with COVID-19 anxiety syndrome, depression and health anxiety
    Distaso, Walter
    Malik, Mohammad M. A. H.
    Semere, Saba
    AlHakami, Amal
    Alexander, Emma C.
    Hirani, Dhruti
    Shah, Ronak J.
    Suba, Kinga
    McKechnie, Vicky
    Nikcevic, Ana
    Oliver, Nick
    Spada, Marcantonio
    Salem, Victoria
    DIABETIC MEDICINE, 2022, 39 (10)
  • [3] Self-management for elderly during the COVID-19 pandemic
    Rahman, Md Sazedur
    Lassi, Zohra S.
    BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2021, 20 (03): : 694 - 695
  • [4] Depression and anxiety during COVID-19 pandemic
    Nicolini, Humberto
    CIRUGIA Y CIRUJANOS, 2020, 88 (05): : 542 - 547
  • [5] The Prevalence of Pandemic Anxiety, Anxiety and Depression During the COVID-19 Pandemic in Turkey
    Firat, Meryem
    Okanli, Ayse
    Kanbay, Yalcin
    Utkan, Mehmet
    Gokmen, Burcu Demir
    PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2021, 31 (02) : 198 - 205
  • [6] Impact of Changed Use of Greenspace during COVID-19 Pandemic on Depression and Anxiety
    Heo, Seulkee
    Desai, Miraj U.
    Lowe, Sarah R.
    Bell, Michelle L.
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (11)
  • [7] Diabetes self-management amid COVID-19 pandemic
    Banerjee, Mainak
    Chakraborty, Soumen
    Pal, Rimesh
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) : 351 - 354
  • [8] INCREASED DEPRESSION AND ANXIETY DURING THE COVID-19 PANDEMIC REGARDLESS OF COVID-19 POSITIVITY
    Ujvari, Cady
    Van den Hurk, Alicia Villanueva
    Mueller, Colette
    Sabal, Patricia
    Greenspan, Noah
    Del Pozzo, Jill
    Malaspina, Dolores
    Walsh-Messinger, Julie
    PSYCHOSOMATIC MEDICINE, 2022, 84 (05): : A56 - A56
  • [9] Prevalence of Depression, Anxiety, and Stress during COVID-19 Pandemic
    Lakhan, Ram
    Agrawal, Amit
    Sharma, Manoj
    JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2020, 11 (04) : 519 - 525
  • [10] Depression and Anxiety in Medical Students during the COVID-19 Pandemic
    Nair, Karthika
    Joseph, Tiffany
    Villamil, Maria Elena
    GLOBAL JOURNAL OF MEDICAL PHARMACEUTICAL AND BIOMEDICAL UPDATE, 2022, 17 (09):